PARP inhibitor (SOTIO Biotech)

N/A

Report date: 2025/06/11 10:36:29
NME

Base Information

Drug NamePARP inhibitor (SOTIO Biotech)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionImmunostimulantsPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSOTIO Biotech a s
China Registration ClassN/A

Develop Information

Active CompaniesSOTIO Biotech a s
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A